VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

Gathering Around Cancer 2020 | Osimertinib for EGFR-mutant lung cancer

Jarushka Naidoo, MBBCh, Beaumont Hospital, Dublin, Ireland, outlines the approval and reimbursement of osimertinib in patients with EGFR mutant non-small cell lung cancer, based on the results of the FLAURA study. (NCT02296125). This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology)

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter